IMM 1.23% 40.0¢ immutep limited

prima biomed - nasdaq 101, page-15

  1. 5,330 Posts.
    lightbulb Created with Sketch. 32
    I agree with you 4walls. Mellon would've organised a nominee to put their bots into action some time ago imo.

    Thanks kindly for sharing your information on here Philbar,

    Whilst some here have pondered over MR's answer to question #5, I believe MR is giving a lot more away with the first 6 words he used in answer to your question #6 ;)

    Question 6.
    Do you have any more rabbits to pull out of your hat like the cap raising and the ' Duabi medical centre announcement ?
    Answer
    " 6. I would answer this to say it is a pleasure to provide a much needed cancer vaccine for cancer patients"


    From Prima's last update:
    Phase III trial for ovarian cancer patients in remission planned to commence by 3rd Quarter 2011 (Europe, USA, Australia)

    Remember phasellb and phaselll will be running concurrently in the US...

    And the following link shows that the "Clinical Trials" register has just been updated in June for the first time since February this year - All centres are now highlighted as Recruiting

    Click HERE and scroll down

    Click HERE for CVac Clinical Trial Update after June 01, 2011

    We all understand how important a full SPP subscription is to Prima, so imo there's no doubt they will be pulling more "rabbits from the hat" before the June 24 closing date.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $581.0M
Open High Low Value Volume
41.0¢ 41.5¢ 39.5¢ $1.576M 3.906M

Buyers (Bids)

No. Vol. Price($)
1 2506 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 8079 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.